Fig. 5From: Thy-1 predicts poor prognosis and is associated with self-renewal in ovarian cancerRNA in situ hybridization of human ovarian cancer tissue. RNA in situ hybridization was performed on human ovarian tissue and graded by a pathologist from 1+ to 3+. Both Patient 4 (a, b) and Patient 2 (c, d) had serous ovarian cancer demonstrated Hematoxylin and Eosin (H&E) at 400x (a, c). Patient 4 demonstrated 3+ ISH for Thy-1 (b) and Patient 2 demonstrated 1+ ISH for Thy-1 (d)Back to article page